DiaSino® recently passed the annual audit of ISO 13485:2016 QMS, which was carried out by notified body BSI.
DiaSino Laboratories announces the completion of the acquisition of ZLEQUIP Company
DiaSino® attends Medlab Middles East 2023 exhibition which takes place in Dubai between Feb 6-9, 2023
DiaSino® announces Exclusive Distributor of ELISA reagents in Bangladesh
DiaSino has been selected by China National Institutes for Food and Drug Control and has participated in the ASSIGNMENT of new batch TSH Calibrators
DiaSino has obtained ISO 13485:2016 quality management system certificate
DiaSino® offers an expansive portfolio of immunoassays to enhance the diagnosis and management of the disease states and conditions that impact women
Image by Freepik